BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4907390)

  • 21. A new butyrophenone: trifluperidol. A psychiatric evaluation in a pediatric setting.
    Le Vann LJ
    Can Psychiatr Assoc J; 1968 Jun; 13(3):271-3. PubMed ID: 5661691
    [No Abstract]   [Full Text] [Related]  

  • 22. Sympatholytic treatment of "paralytic" ileus.
    Petri G; Szenohradszky J; Porszasz-Gibiszer K
    Surgery; 1971 Sep; 70(3):359-67. PubMed ID: 5568520
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effect of triperidol].
    Cwynar S; Pionkowski J; Tomczak W; Tyszka E
    Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
    Kristjansen P
    Nord Psykiatr Tidsskr; 1968; 22(3):235-48. PubMed ID: 5711258
    [No Abstract]   [Full Text] [Related]  

  • 25. [Radioprotective properties of butyrophenone derivatives].
    Uray Z; Farcasanu M; Maniu M
    Agressologie; 1970; 11(4):357-60. PubMed ID: 5485665
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study with hydrothiadene in endogenous depression. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Svestka J; Rodová A; Misurec J
    Act Nerv Super (Praha); 1970 Jan; 12(1):62-3. PubMed ID: 4907393
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the position of butyrophenone derivative Triperidol in psychiatric treatment].
    Lange E; Scholz V
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875
    [No Abstract]   [Full Text] [Related]  

  • 28. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 29. [Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
    Radzuweit H; Knorr W
    Endokrinologie; 1969; 54(1):111-7. PubMed ID: 5358570
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
    [No Abstract]   [Full Text] [Related]  

  • 31. [Central and peripheral secondary effects of some butyrophenones].
    Salvini L; Frosali L; Gigli M
    Minerva Anestesiol; 1969 Apr; 35(4):334-44. PubMed ID: 5789993
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study.
    Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S
    J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic evaluation of R2498 (triperidol) in hospitalized schizophrenic patients].
    Bueno JR
    J Bras Psiquiatr; 1965; 14(1):81-91. PubMed ID: 5888213
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic results obtained with triperidol in a group of chronic schizophrenics].
    Motta E; Spadaro P
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Jun; 91(3):802-17. PubMed ID: 5614833
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 37. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
    Menon MS; Ramachandran V
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 39. Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
    Svestka J; Cesková E; Rysánek R; Náhunek K
    Act Nerv Super (Praha); 1989 Dec; 31(4):276-7. PubMed ID: 2576922
    [No Abstract]   [Full Text] [Related]  

  • 40. Electroencephalographic effects of trifluperidol.
    Itil T; Fink M
    Dis Nerv Syst; 1969 Aug; 30(8):524-30. PubMed ID: 5809787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.